Expression levels of ALPL, BGLAP, and TNF were not significantly different between control and osteoporosis groups (Fig. 4b–d), but those of ACP5 and CTSK were significantly increased in patients with osteoporosis compared to those in the controls (Fig. 4e, f). The gene discussed is ACP5; the disease is osteoporosis.